Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NV › LAS VEGAS › SUNRISE MOUNTAINVIEW HOSPITAL, INC.

SUNRISE MOUNTAINVIEW HOSPITAL, INC.

NPI: 1013961093 · LAS VEGAS, NV 89128 · General Acute Care Hospital · NPI assigned 05/22/2006

$5.20M
Total Medicaid Paid
453,585
Total Claims
338,087
Beneficiaries
158
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialKILLIAN, STEVE (CFO)
NPI Enumeration Date05/22/2006

Related Entities

Other providers sharing the same authorized official: KILLIAN, STEVE

ProviderCityStateTotal Paid
SUNRISE MOUNTAIN VIEW HOSPITAL, INC. NORTH LAS VEGAS NV $770K
SUNRISE MOUNTAINVIEW HOSPITAL, INC. LAS VEGAS NV $75K
SUNRISE MOUNTAINVIEW HOSPITAL, INC. LAS VEGAS NV $4.42

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 78,921 $792K
2019 97,788 $1.02M
2020 70,402 $693K
2021 60,261 $704K
2022 56,664 $686K
2023 60,511 $770K
2024 29,038 $536K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 8,986 6,981 $1.22M
99284 Emergency department visit for the evaluation and management, high severity 19,826 16,183 $1.01M
99283 Emergency department visit for the evaluation and management, moderate severity 16,240 13,862 $801K
74177 Computed tomography, abdomen and pelvis; with contrast material 4,194 3,332 $781K
70450 Computed tomography, head or brain; without contrast material 5,165 4,336 $468K
71275 Computed tomographic angiography, chest, with contrast material 1,369 1,084 $232K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,313 1,126 $175K
G0378 Hospital observation service, per hour 5,455 3,690 $107K
93975 356 273 $105K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 2,049 735 $67K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2,016 1,767 $50K
72125 Computed tomography, cervical spine; without contrast material 1,641 1,420 $25K
76700 Ultrasound, abdominal, real time with image documentation; complete 352 285 $23K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 56 39 $18K
96375 Therapeutic injection; each additional sequential IV push 7,526 5,172 $13K
93970 154 138 $10K
87040 7,567 3,848 $9K
78492 33 30 $8K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 23,259 17,863 $8K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 340 278 $7K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 11,562 9,213 $7K
71045 Radiologic examination, chest; single view 14,932 12,018 $6K
99281 Emergency department visit for the evaluation and management, self-limited or minor 459 409 $5K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,612 5,260 $3K
96361 Intravenous infusion, hydration; each additional hour 6,546 4,846 $3K
93976 559 452 $3K
71046 Radiologic examination, chest; 2 views 3,474 3,060 $3K
85027 35,767 24,957 $3K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,733 2,000 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 489 405 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 6,529 3,923 $1K
97163 1,140 827 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2,179 1,795 $1K
93971 562 492 $1K
80076 9,624 7,689 $1K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 214 189 $967.40
84484 18,928 12,090 $928.69
84443 Thyroid stimulating hormone (TSH) 2,154 1,669 $886.47
80048 Basic metabolic panel (calcium, ionized) 9,964 7,505 $819.68
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 649 374 $747.41
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 139 24 $746.74
84703 7,365 6,025 $697.32
83880 5,837 4,854 $668.88
87088 3,326 2,814 $652.45
81001 12,735 10,329 $644.33
80047 8,721 6,909 $640.47
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,329 3,431 $633.18
J0696 Injection, ceftriaxone sodium, per 250 mg 2,460 1,833 $617.80
J7030 Infusion, normal saline solution , 1000 cc 10,114 7,706 $567.34
87070 669 540 $562.20
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 605 506 $526.68
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 606 507 $502.74
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,389 1,946 $492.84
80053 Comprehensive metabolic panel 17,805 13,605 $457.43
84702 1,462 1,136 $401.22
76830 Ultrasound, transvaginal 351 293 $391.60
83690 9,544 7,508 $388.93
82550 7,631 5,762 $358.34
97530 Therapeutic activities, direct patient contact, each 15 minutes 62 12 $345.99
73564 360 319 $333.20
83605 3,365 2,343 $317.20
80069 179 103 $301.60
96376 2,218 1,083 $281.92
85610 14,599 11,562 $281.33
85730 11,333 9,036 $240.70
P9016 Red blood cells, leukocytes reduced, each unit 65 51 $231.15
86850 2,311 1,807 $226.61
72100 383 352 $210.25
81025 2,249 1,908 $198.24
73630 426 381 $194.71
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 334 274 $187.96
J2765 Injection, metoclopramide hcl, up to 10 mg 1,288 1,044 $180.31
J7050 Infusion, normal saline solution, 250 cc 4,152 2,990 $166.91
73130 142 119 $156.60
86920 61 57 $151.80
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 266 176 $145.75
97161 35 28 $141.10
74018 226 203 $139.19
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 214 173 $128.28
83735 5,337 3,574 $123.39
97162 68 63 $99.58
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 350 299 $98.16
86900 3,267 2,592 $87.24
86901 3,268 2,593 $85.20
J1885 Injection, ketorolac tromethamine, per 15 mg 5,945 3,244 $83.57
J7120 Ringers lactate infusion, up to 1000 cc 1,884 1,279 $83.42
83036 Hemoglobin; glycosylated (A1C) 1,207 931 $79.92
85379 595 492 $78.45
82805 223 166 $77.44
84439 864 665 $67.65
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 275 186 $60.25
82330 61 40 $59.41
87210 753 640 $52.21
81003 2,202 1,815 $51.92
J1200 Injection, diphenhydramine hcl, up to 50 mg 3,214 2,417 $51.01
82553 384 331 $47.28
J2270 Injection, morphine sulfate, up to 10 mg 2,286 1,648 $45.33
J2405 Injection, ondansetron hydrochloride, per 1 mg 6,229 4,623 $45.22
82248 3,349 2,482 $35.57
73030 378 319 $33.36
J1630 Injection, haloperidol, up to 5 mg 680 486 $31.55
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,536 1,202 $30.72
85049 28 26 $29.55
87186 634 496 $29.50
73610 150 132 $26.85
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 534 423 $25.30
82140 565 455 $25.30
84100 1,691 1,123 $19.38
J1170 Injection, hydromorphone, up to 4 mg 476 291 $18.57
80061 Lipid panel 1,023 776 $18.28
86140 264 233 $17.65
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,343 1,147 $17.35
J0456 Injection, azithromycin, 500 mg 99 67 $16.74
87430 295 273 $16.36
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 259 166 $11.31
83050 14 12 $10.00
85652 161 145 $7.40
J3370 Injection, vancomycin hcl, 500 mg 62 41 $5.00
J1815 Injection, insulin, per 5 units 1,167 508 $4.33
J2060 Injection, lorazepam, 2 mg 1,644 1,194 $3.75
J1650 Injection, enoxaparin sodium, 10 mg 311 183 $3.48
87205 38 26 $2.91
J3475 Injection, magnesium sulfate, per 500 mg 193 117 $2.52
J3010 Injection, fentanyl citrate, 0.1 mg 785 605 $0.89
S0028 Injection, famotidine, 20 mg 170 139 $0.88
A9270 Non-covered item or service 10,555 3,441 $0.00
11045 115 12 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 359 280 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 287 244 $0.00
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 365 314 $0.00
J0690 Injection, cefazolin sodium, 500 mg 24 12 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 116 102 $0.00
J2704 Injection, propofol, 10 mg 645 541 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 153 116 $0.00
36430 35 24 $0.00
73502 61 52 $0.00
J8540 Dexamethasone, oral, 0.25 mg 17 14 $0.00
96368 50 12 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 106 89 $0.00
J1940 Injection, furosemide, up to 20 mg 44 13 $0.00
C1769 Guide wire 13 12 $0.00
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 50 46 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 28 15 $0.00
J3490 Unclassified drugs 88 55 $0.00
J7999 Compounded drug, not otherwise classified 15 12 $0.00
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 14 13 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 57 40 $0.00
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries 33 30 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 66 65 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 66 65 $0.00
86923 16 12 $0.00
J1644 Injection, heparin sodium, per 1000 units 247 132 $0.00
93017 160 128 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 39 36 $0.00
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 39 28 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 19 12 $0.00
97167 20 14 $0.00
87631 93 77 $0.00